Dose Range Finding Study of Bimagrumab in Sarcopenia
Clinical trial NCT02333331 · COMPLETED
Trial details
- NCT number
- NCT02333331
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-09
- Primary completion
- 2018-06-26
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.